Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hilbe, W; Aigner, K; Dittrich, C; Eckmayr, J; Fiegl, M; Flicker, M; Forstner, B; Greil, R; Jamnig, H; Krajnik, G; Lang, A; Mohn-Staudner, A; Schinko, H; Studnicka, M; Pirker, R; Ploner, F; Rothmund, J; Schiller, L; Zabernigg, A; Zöchbauer-Müller, S.
Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms
WIEN KLIN WOCHENSCHR. 2007; 119(7-8): 259-266.
Doi: 10.1007/s00508-007-0792-5
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Ploner Ferdinand
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Antineoplastic Agents - administration and dosage
-
Austria - administration and dosage
-
Bronchial Neoplasms - drug therapy
-
Carcinoma, Non-Small-Cell Lung - drug therapy
-
Practice Guidelines as Topic - drug therapy
-
Societies, Medical - drug therapy
- Find related publications in this database (Keywords)
-
Lung cancer
-
Second line therapy
-
Erlotinib
-
Pemetrexed
-
Docetaxel